Your Source for BioScience Venture Capital Data
  • OnBioVC NEWS:

    - OnBioVC Announces Beta Launch of Service
    - OnBioVC INDEX(TM) Updated thru DEC 2009
    - OnBioVC 2009 Year-in-Review, now available
    - OnBioVC 1Q10 Trend Analysis, coming soon
  • SEARCH THE OnBioVC DATABASE:

  • business strategy life science

Nautilus Neurosciences (Bridgewater, NJ) near commercial-stage specialty neurology pharma focused on migraine and acute pain, closed a $14.5M Series A financing. Participants include Tailwind Capital.
_________________________________________________________________________
NOTE: New OnBioVC Friday feature coming, well…this Friday!

Eleven Biotherapeutics (Cambridge, MA) a preclinical-stage biopharmaceutical company focused on protein therapeutics for the treatment of inflammation and coagulation disorders, closed a $35M Series A financing. Participants include Flagship Ventures and Third Rock Ventures.
_________________________________________________________________________
NOTE: New OnBioVC Friday feature coming, well…this Friday!

TheraSim (Durham, NC) a commercial-stage medical technology company focused on a suite of clinical performance management tools, closed a $1.2M Series A financing. Participants include Andromeda Capital.

F-star Biotech (Austria) a development-stage based biopharma company focused upon an antibody design platform, with product and indication(s) to be identified, closed a $10.8M Series A financing, bringing the total round to $25.8M. Participants include MP Healthcare Venture Management, Merck Serono Ventures, Atlas Venture, Aescap Venture, Novo Ventures and TVM Capital.

Flexion Therapeutics (Woburn, MA) a clinical-stage biopharma focused on autoimmune disease, ulcerative colitis and tinnitus, closed a $9M Series A financing, bringing the total round to $42M. Participants include Pfizer Venture Investments, Versant Ventures, 5AM Ventures and Sofinnova Ventures.

Elevation Pharmaceuticals (San Diego, CA) a preclinical-stage biopharmaceutical company focused on developing improved inhaled drug therapies for COPD , closed a $30M Series A financing. Participants include Canaan Partners, TPG Growth, Care Capital and Mesa Verde Venture Partners.

TVA Medical (Austin, TX) a development-stage medical device company focused on a minimally invasive approach for the treatment of end-stage renal disease, closed a $2.6M Series A financing. Participants include Santé Ventures.

CeQur (Switzerland) a development-stage device company focused on a wearable insulin infuser for the continuous subcutaneous delivery of insulin for Type II diabetes, closed a $29.6M Series A financing. Participants include BMC Ventures, Endeavour Vision, Schroders and Venture Incubator.

HistoSonics (Ann Arbor, MI) a development stage device company focused on non-invasive image-guided tissue ablation for benign prostatic hyperplasia, closed an $11M Series A financing. Participants include Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Early Stage Partners and TGap Ventures.

Acton Pharmaceuticals (Marlborough, MA) a near commercial-stage pharmaceutical company focused on a HFA-propelled aerosol inhaled corticosteroid for the treatment of asthma, closed a $15M Series A financing. Participants include Sequoia Capital.

« Previous Entries  

to top of page...